Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05061732
PHASE4

Helicobacter Pylori Eradication and Follow-up

Sponsor: Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

This randomized controlled clinical trial will estimate the eradication efficacy of different therapy for Helicobacter pylori treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.

Official title: Helicobacter Pylori Eradication and Follow-up in Zhongshan Hospital

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

4447

Start Date

2021-09-30

Completion Date

2026-06-30

Last Updated

2021-09-30

Healthy Volunteers

No

Interventions

DRUG

Rabeprazole

20mg bid

DRUG

Bismuth potassium citrate

0.6g bid

DRUG

Metronidazole

0.4g qid

DRUG

Clarithromycin

0.5g bid

DRUG

Levofloxacin

0.5g qd

DRUG

Amoxicillin

1g tid

DRUG

Metronidazole

0.4g tid

DRUG

Doxycycline

0.1g bid

DRUG

Tetracycline

0.5g qid

Locations (1)

Zhongshan Hospital, Fudan University

Shanghai, Shanghai Municipality, China